Literature DB >> 397198

Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan.

N R Di Luzio, D L Williams, R B McNamee, B F Edwards, A Kitahama.   

Abstract

A soluble fraction of particulate glucan was prepared and evaluated for its anti-tumor and anti-bacterial activity. Thin-layer chromatographic analysis indicated that the soluble preparation was composed of a variety of polyglucoses. Intravenous administration of soluble or particulate glucan resulted in significant reductions in the growth of a syngeneic anaplastic mammary carcinoma and melanoma B16. Survival data demonstrated that intravenous administration of soluble or particulate glucan prolonged survival of A/J and C57BL/6J mice with subcutaneous tumor implants. As regards to bacterial infections, soluble and particulate glucan decreased renal necrosis in S. aureus challenged mice as compared to control mice. Although the exact nature of the active soluble fraction(s) of glucan remains to be delineated, these studies demonstrate that a soluble glucan preparation exhibits significant anti-tumor and anti-staphylococcal activity. The active soluble fraction of particulate glucan may be preferable to particulate glucan in view of the inherent ease of parenteral administration.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 397198     DOI: 10.1002/ijc.2910240613

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

1.  Acute pulmonary toxicity of inhaled beta-1,3-glucan and endotoxin.

Authors:  B Fogelmark; H Goto; K Yuasa; B Marchat; R Rylander
Journal:  Agents Actions       Date:  1992-01

2.  Structural insights into recognition of triple-helical beta-glucans by an insect fungal receptor.

Authors:  Mayumi Kanagawa; Tadashi Satoh; Akemi Ikeda; Yoshiyuki Adachi; Naohito Ohno; Yoshiki Yamaguchi
Journal:  J Biol Chem       Date:  2011-06-22       Impact factor: 5.157

3.  Protective effect of glucan against visceral leishmaniasis in hamsters.

Authors:  J A Cook; T W Holbrook; W J Dougherty
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

4.  Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways.

Authors:  Bing Li; Daniel Cramer; Stephanie Wagner; Richard Hansen; Chelsea King; Shelly Kakar; Chuanlin Ding; Jun Yan
Journal:  Clin Immunol       Date:  2007-06-14       Impact factor: 3.969

5.  Immunogenicity of soluble and particulate antigens from Leishmania donovani: effect of glucan as an adjuvant.

Authors:  J A Cook; T W Holbrook
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

6.  Adverse effects of pefloxacin in irradiated C3H/HeN mice: correction with glucan therapy.

Authors:  M L Patchen; I Brook; T B Elliott; W E Jackson
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

7.  Inhibition (in vitro) of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia.

Authors:  T S Tochikura; H Nakashima; Y Ohashi; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

8.  Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction.

Authors:  M Otterlei; A Sundan; G Skjåk-Braek; L Ryan; O Smidsrød; T Espevik
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Sensitivity of Limulus amebocyte lysate (LAL) to LAL-reactive glucans.

Authors:  P F Roslansky; T J Novitsky
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

10.  Effects of pre- and post-irradiation glucan treatment on pluripotent stem cells, granulocyte, macrophage and erythroid progenitor cells, and hemopoietic stromal cells.

Authors:  M L Patchen; T J MacVittie; L M Wathen
Journal:  Experientia       Date:  1984-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.